Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine
Authors:
Open Access
- 20 March 2017
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 13 (6) , 1314-1319
Abstract
In China, both inactivated hepatitis A (HA) vaccine and live attenuated HA vaccine are available. We conducted a trial to evaluate 5-year immune persistence induced by one dose of inactivated or live attenuated HA vaccines in children. Subjects with no HA vaccination history had randomly received one dose of inactivated or live attenuated HA vaccine at 18–60 months of age. Anti-HAV antibody concentrations were measured before vaccination and at the first, second, and fifth year after vaccination. Suspected cases of hepatitis A were monitored during the study period. A total of 332 subjects were enrolled and 182 provided evaluable serum samples at all planned time points. seropositive rate at 5 y was 85.9% in the inactivated HA vaccine group and 90.7% in the live attenuated HA vaccine group. GMCs were 76.3% mIU/ml (95% CI: 61.7 – 94.4) and 66.8mIU/ml (95% CI: 57.8 – 77.3), respectively. No significant difference in antibody persistence between 2 groups was found. No clinical hepatitis A case was reported. A single dose of an inactivated or live attenuated HA vaccine at 18–60 months of age resulted in high HAV seropositive rate and anti-HAV antibody concentrations that lasted for at least 5 y.Keywords
This publication has 18 references indexed in Scilit:
- Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 YearsJournal of the Pediatric Infectious Diseases Society, 2014
- Cost-effectiveness of hepatitis A vaccination in IndonesiaHuman Vaccines & Immunotherapeutics, 2014
- Effectiveness of 10-year vaccination (2001–2010) for Hepatitis A in Tianjin, ChinaHuman Vaccines & Immunotherapeutics, 2014
- Live attenuated hepatitis A vaccines developed in ChinaHuman Vaccines & Immunotherapeutics, 2013
- Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccinesHuman Vaccines & Immunotherapeutics, 2013
- Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®Human Vaccines & Immunotherapeutics, 2012
- Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese childrenVaccine, 2012
- Comparing live attenuated and inactivated hepatitis A vaccines: An immunogenicity study after one single doseVaccine, 2011
- Hepatitis A Surveillance and Vaccine Use in China From 1990 Through 2007Journal of Epidemiology, 2009
- Incidence of Hepatitis A in Argentina after vaccinationJournal of Viral Hepatitis, 2008